DNMT3A and neoplasm: Unlike what happens in patients with TBRS and in AML and other neoplasia, in which the gene is usually inactivated by loss-of-function alterations, we demonstrated that DNMT3A-mutated PGLs exhibited a significant overall methylation, indicating an activating role of the variants.